---
title: "Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation | AMIX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286772951.md"
description: "Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation | AMIX Stock News"
datetime: "2026-05-18T04:45:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286772951.md)
  - [en](https://longbridge.com/en/news/286772951.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286772951.md)
---

# Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation | AMIX Stock News

Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation | AMIX Stock News

### Related Stocks

- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)

## Related News & Research

- [Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study | DWTX Stock News](https://longbridge.com/en/news/286772955.md)
- [US Cancer Clinics Rush to Access Revolutionary Pancreatic Cancer Drug Daraxonrasib](https://longbridge.com/en/news/286405546.md)
- [Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer | SLXN Stock News](https://longbridge.com/en/news/286425411.md)
- [Cancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report](https://longbridge.com/en/news/286590889.md)
- [AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer | AIM Stock News](https://longbridge.com/en/news/286419549.md)